News
A week later, Abraham woke up in the middle of the night and tried to stand. She collapsed to the floor, struggling to ...
As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...
7d
MedPage Today on MSNTargeted Treatment Improves Disability in Guillain-Barre SyndromeThe primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with tanruprubart at a dose of 30 mg/kg recovered to a healthy state with a score of 0 or ...
23d
Amazon S3 on MSNWhat is Guillain-Barré syndrome?Scientists have linked Zika firmly to Guillain-Barré syndrome, known for triggering temporary paralysis.
Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground.
Guillain-Barré Syndrome: The Frightening Illness Linked to Your Favourite Foods.(Photo by RDNE Stock) She pointed out, “A plant-based diet of whole foods naturally enhances immunity by ...
SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III ...
This announcement was made alongside the reveal of positive Phase 3 results for Tanruprubart, a monoclonal antibody that can block C1q and can potentially halt neuroinflammation and nerve damage in ...
Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...
4don MSN
Megyn Kelly, the American journalist, regrets her decision to get the Covid-19 vaccine, citing an autoimmune diagnosis ...
We present a case of Guillain-Barré syndrome in a child who received hepatitis A vaccine 5 days before onset of the clinical symptoms. In our patient, the association of Guillain-Barré syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results